Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

20.55USD
15 Dec 2017
Change (% chg)

$0.18 (+0.88%)
Prev Close
$20.37
Open
$20.36
Day's High
$20.58
Day's Low
$20.35
Volume
288,923
Avg. Vol
65,645
52-wk High
$22.41
52-wk Low
$17.68

Latest Key Developments (Source: Significant Developments)

Luminex Corp reports Q3 earnings per share $0.40
Monday, 30 Oct 2017 04:05pm EDT 

Oct 30 (Reuters) - Luminex Corp :Luminex Corporation reports third quarter 2017 financial results.Q3 gaap earnings per share $0.40.Q3 revenue $74.1 million versus i/b/e/s view $74.4 million.Q3 earnings per share view $0.10 -- Thomson Reuters I/B/E/S.Q3 non-gaap earnings per share $0.25.Sees Q4 2017 revenue $76 million to $78 million.Luminex Corp - reaffirms guidance for full year​.  Full Article

Zicom Group says settlement agreement has been reached​ on ‍lawsuit filed by Luminex Corporation against Curiox Biosystems
Tuesday, 24 Oct 2017 11:19pm EDT 

Oct 25 (Reuters) - Zicom Group Ltd :Refers to ‍lawsuit filed by luminex corporation against curiox biosystems; advises settlement agreement has been reached​.  Full Article

Luminex Corp - Labcorp agrees to extend commitment to Luminex Cystic Fibrosis
Monday, 11 Sep 2017 05:13pm EDT 

Sept 12 (Reuters) - Laboratory Corporation Of America Holdings :Luminex Corp - Agreement with Labcorp whereby Labcorp agreed to extend commitment to the Luminex Cystic Fibrosis product line through December 31, 2019.  Full Article

Luminex Corporation Q2 earnings per share $0.13
Monday, 7 Aug 2017 04:05pm EDT 

Aug 7 (Reuters) - Luminex Corp :Luminex Corporation reports second quarter 2017 financial results.Q2 GAAP earnings per share $0.13.Sees Q3 2017 revenue $73 million to $75 million.Q2 revenue $76.5 million versus I/B/E/S view $75.5 million.Q2 non-GAAP earnings per share $0.26.Sees FY 2017 revenue $300 million to $310 million.Q2 earnings per share view $0.10 -- Thomson Reuters I/B/E/S.FY 2017 revenue view $306.6 million -- Thomson Reuters I/B/E/S.Q3 revenue view $76.2 million -- Thomson Reuters I/B/E/S.  Full Article

Luminex Corporation receives FDA clearance for ARIES C. difficile assay
Monday, 24 Jul 2017 08:30am EDT 

July 24 (Reuters) - Luminex Corp :Luminex Corporation receives FDA clearance for ARIES C. difficile assay.Luminex Corp - received FDA clearance for ARIES C. difficile assay, a moderate complexity, sample to answer test for rapid detection of C. difficile​.  Full Article

Luminex Corp received CE-IVD marking for ARIES Norovirus Assay
Wednesday, 28 Jun 2017 08:00am EDT 

June 28 (Reuters) - Luminex Corp :Luminex Corp - Received CE-IVD marking for ARIES Norovirus Assay.  Full Article

Luminex Corp receives FDA clearance for Aries Bordetella Assay
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Luminex Corp : :Luminex Corporation receives FDA clearance for Aries Bordetella Assay.Luminex Corp- also achieved ce-ivd marking for Aries Bordetella Assay, is preparing to submit its clostridium difficile assay to FDA later this month.Luminex Corp- also is in process of completing a group a streptococcus clinical trial as it seeks to further expand its Aries menu.  Full Article

Luminex Corp Q1 gaap earnings per share $0.21
Monday, 1 May 2017 04:05pm EDT 

May 1 (Reuters) - Luminex Corp ::Luminex Corp says Q1 total Verigene related revenue of $10.5 million; growth of 59% over its Q1 2016.Luminex Corporation reports record first quarter 2017 financial results; raises 2017 financial guidance.Q1 GAAP earnings per share $0.21.Sees q2 2017 revenue $74 million to $76 million.Q1 revenue $77.8 million versus I/B/E/S view $74.2 million.Q1 non-GAAP earnings per share $0.28.Sees fy 2017 revenue $300 million to $310 million.Q1 earnings per share view $0.07 -- Thomson Reuters I/B/E/S.Q2 earnings per share view $0.07, revenue view $75.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $0.32, revenue view $301.3 million -- Thomson Reuters I/B/E/S.  Full Article

Luminex Corp announces cash dividend of $0.06
Tuesday, 21 Feb 2017 04:05pm EST 

Luminex Corp : Luminex corporation announces initiation of cash dividend .Luminex corp - board of directors intends for company to pay a regular quarterly cash dividend of $0.06 to holders of its common stock,.  Full Article

Luminex corporation reports Q4 GAAP loss per share $0.08
Monday, 6 Feb 2017 04:05pm EST 

Luminex Corp : Luminex Corporation reports fourth quarter and full year 2016 results . Q4 GAAP loss per share $0.08 . Sees Q1 2017 revenue $73 million to $75 million . Q4 earnings per share view $0.09 -- Thomson Reuters I/B/E/S . Sees FY 2017 revenue $295 million to $305 million . Q4 non-GAAP earnings per share $0.11 . Luminex Corp- Luminex reiterates its 2017 annual revenue guidance range to between $295 million and $305 million . Luminex Corp- anticipates Q1 2017 revenue to be between $73 million and $75 million . FY2017 earnings per share view $0.51, revenue view $299.6 million -- Thomson Reuters I/B/E/S .Q1 revenue view $74.2 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Luminex Corporation receives FDA clearance for Aries Group A Strep Assay

* Luminex Corporation receives FDA clearance for Aries Group A Strep Assay Source text for Eikon: Further company coverage: